147 related articles for article (PubMed ID: 34979570)
41. Evaluation of Mutational Testing of Preneoplastic Barrett's Mucosa by Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Endoscopic Samples for Detection of Concurrent Dysplasia and Adenocarcinoma in Barrett's Esophagus.
Del Portillo A; Lagana SM; Yao Y; Uehara T; Jhala N; Ganguly T; Nagy P; Gutierrez J; Luna A; Abrams J; Liu Y; Brand R; Sepulveda JL; Falk GW; Sepulveda AR
J Mol Diagn; 2015 Jul; 17(4):412-9. PubMed ID: 26068095
[TBL] [Abstract][Full Text] [Related]
42. Who Deserves Endoscopic Screening for Esophageal Neoplasia?
Blevins CH; Iyer PG
Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):365-378. PubMed ID: 28577762
[TBL] [Abstract][Full Text] [Related]
43. Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort.
Gaddam S; Singh M; Balasubramanian G; Thota P; Gupta N; Wani S; Higbee AD; Mathur SC; Horwhat JD; Rastogi A; Young PE; Cash BD; Bansal A; Vargo JJ; Falk GW; Lieberman DA; Sampliner RE; Sharma P
Gastroenterology; 2013 Sep; 145(3):548-53.e1. PubMed ID: 23714382
[TBL] [Abstract][Full Text] [Related]
44. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
[TBL] [Abstract][Full Text] [Related]
45. Low Risk of Progression of Barrett's Esophagus to Neoplasia in Women.
Allen JE; Desai M; Roumans CAM; Vennalaganti S; Vennalaganti P; Bansal A; Falk G; Lieberman D; Sampliner R; Thota P; Vargo J; Gupta N; Moawad F; Bruno M; Kennedy KF; Gaddam S; Young P; Mathur S; Cash B; Spaander M; Sharma P
J Clin Gastroenterol; 2021 Apr; 55(4):321-326. PubMed ID: 32379085
[TBL] [Abstract][Full Text] [Related]
46. Critical reappraisal of current surveillance strategies for Barrett's esophagus: analysis of a large German Barrett's database.
von Rahden BH; Stein HJ; Weber A; Vieth M; Stolte M; Rösch T; Schmid RM; Sarbia M; Meining A
Dis Esophagus; 2008; 21(8):685-9. PubMed ID: 18847456
[TBL] [Abstract][Full Text] [Related]
47. Low incidence of adenocarcinoma and high-grade intraepithelial neoplasia in patients with Barrett's esophagus: a prospective cohort study.
Martinek J; Benes M; Brandtl P; Hucl T; Vasicek M; Voska L; Lanska V; Nosek V; Spicak J
Endoscopy; 2008 Sep; 40(9):711-6. PubMed ID: 18698534
[TBL] [Abstract][Full Text] [Related]
48. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
[TBL] [Abstract][Full Text] [Related]
49. Endoscopic therapy of esophageal premalignancy and early malignancy.
Nealis TB; Washington K; Keswani RN
J Natl Compr Canc Netw; 2011 Aug; 9(8):890-9. PubMed ID: 21900219
[TBL] [Abstract][Full Text] [Related]
50. Advanced imaging technologies increase detection of dysplasia and neoplasia in patients with Barrett's esophagus: a meta-analysis and systematic review.
Qumseya BJ; Wang H; Badie N; Uzomba RN; Parasa S; White DL; Wolfsen H; Sharma P; Wallace MB
Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1562-70.e1-2. PubMed ID: 23851020
[TBL] [Abstract][Full Text] [Related]
51. Incidence of esophageal adenocarcinoma in Barrett's esophagus with low-grade dysplasia: a systematic review and meta-analysis.
Singh S; Manickam P; Amin AV; Samala N; Schouten LJ; Iyer PG; Desai TK
Gastrointest Endosc; 2014 Jun; 79(6):897-909.e4; quiz 983.e1, 983.e3. PubMed ID: 24556051
[TBL] [Abstract][Full Text] [Related]
52. Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review.
Wani S; Puli SR; Shaheen NJ; Westhoff B; Slehria S; Bansal A; Rastogi A; Sayana H; Sharma P
Am J Gastroenterol; 2009 Feb; 104(2):502-13. PubMed ID: 19174812
[TBL] [Abstract][Full Text] [Related]
53. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
Wani S; Rubenstein JH; Vieth M; Bergman J
Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
[TBL] [Abstract][Full Text] [Related]
54. Predictors of dysplastic and neoplastic progression of Barrett’s esophagus.
Alnasser S; Agnihotram R; Martel M; Mayrand S; Franco E; Ferri L
Can J Surg; 2019 Apr; 62(2):93-99. PubMed ID: 30907564
[TBL] [Abstract][Full Text] [Related]
55. A Barrett's esophagus registry of over 1000 patients from a specialist center highlights greater risk of progression than population-based registries and high risk of low grade dysplasia.
Picardo SL; O'Brien MP; Feighery R; O'Toole D; Ravi N; O'Farrell NJ; O'Sullivan JN; Reynolds JV
Dis Esophagus; 2015; 28(2):121-6. PubMed ID: 24428806
[TBL] [Abstract][Full Text] [Related]
56. Long-term follow-up of Barrett's high-grade dysplasia.
Weston AP; Sharma P; Topalovski M; Richards R; Cherian R; Dixon A
Am J Gastroenterol; 2000 Aug; 95(8):1888-93. PubMed ID: 10950031
[TBL] [Abstract][Full Text] [Related]
57. Characterization of Prevalent, Post-Endoscopy, and Incident Esophageal Cancer in the United States: A Large Retrospective Cohort Study.
Vajravelu RK; Kolb JM; Thanawala SU; Scott FI; Han S; Singal AG; Falk GW; Katzka DA; Wani S
Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1739-1747. PubMed ID: 33549872
[TBL] [Abstract][Full Text] [Related]
58. Magnitude of Missed Esophageal Adenocarcinoma After Barrett's Esophagus Diagnosis: A Systematic Review and Meta-analysis.
Visrodia K; Singh S; Krishnamoorthi R; Ahlquist DA; Wang KK; Iyer PG; Katzka DA
Gastroenterology; 2016 Mar; 150(3):599-607.e7; quiz e14-5. PubMed ID: 26619962
[TBL] [Abstract][Full Text] [Related]
59. Significantly lower annual rates of neoplastic progression in short- compared to long-segment non-dysplastic Barrett's esophagus: a systematic review and meta-analysis.
Chandrasekar VT; Hamade N; Desai M; Rai T; Gorrepati VS; Jegadeesan R; Sathyamurthy A; Sharma P
Endoscopy; 2019 Jul; 51(7):665-672. PubMed ID: 30939618
[TBL] [Abstract][Full Text] [Related]
60. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated?
Konda VJ; Ross AS; Ferguson MK; Hart JA; Lin S; Naylor K; Noffsinger A; Posner MC; Dye C; Cislo B; Stearns L; Waxman I
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):159-64. PubMed ID: 18096439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]